Sign In
Buy AUTL
$1.62
-0.130 (-7.43%)
At Close: Jun 03, 2026
Autolus Therapeutics to host Investor Conference Calls through June
11:00am, Tuesday, 26'th May 2020
LONDON, May 26, 2020 -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today.
Autolus Notice of Annual General Meeting (AGM) on Thursday, June 18, 2020
11:00am, Friday, 22'nd May 2020
Autolus Therapeutics plc (AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today posted notice of its Annual General Meeting (AGM) to sharehol
Autolus Therapeutics to Present New Data at the Virtual 2020 AACR Annual Meeting
03:20pm, Friday, 15'th May 2020
- Preclinical data on AUTO5 in T cell lymphoma and solid tumor data on AUTO6NG in small cell lung cancer and AUTO7 in prostate cancer - Conference Call and Webcast to be held.
Autolus Therapeutics to Present New Data on AUTO1 and AUTO3 at the 2020 EHA Annual Meeting
11:00am, Friday, 15'th May 2020
– Data builds on positive data presented at American Society of Hematology in December 2019 and EHA-EMBT 2nd European CAR T Cell Meeting in February 2020 – Conference Call.
Autolus Therapeutics to Present New Data on AUTO3 during the ASCO20 Virtual Scientific Program
11:00am, Thursday, 14'th May 2020
- Virtual oral presentation will include additional patient data as well as longer term data on previously treated patients - Conference Call and Webcast to Be Held Monday,.
Is Autolus Therapeutics (AUTL) Stock a Solid Choice Right Now?
01:27pm, Wednesday, 13'th May 2020
Autolus Therapeutics (AUTL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Gene-Therapy Treatments for Tay-Sachs, Sickle Cell, Other Diseases to Be Featured in Online Gathering
05:40pm, Tuesday, 12'th May 2020
This week’s online annual meeting of the American Society for Gene and Cell Therapy will take place on the web.
Autolus Therapeutics PLC Sponsored ADR (AUTL) Upgraded to Strong Buy: What Does It Mean for the Stock?
04:00pm, Tuesday, 12'th May 2020
Autolus Therapeutics PLC Sponsored ADR (AUTL) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in
Will Autolus Therapeutics Continue to Surge Higher?
02:52pm, Tuesday, 12'th May 2020
As of late, it has definitely been a great time to be an investor Autolus Therapeutics
Autolus: A Highly Undervalued CAR-T Company
01:36pm, Tuesday, 12'th May 2020
AUTO1 is uniquely positioned among CD19-targeted CAR-T products due to its fast off-rate kinetics. AUTO1 has low rates of cytokine release syndrome with better
Analyst Estimates: Here's What Brokers Think Of Autolus Therapeutics plc (NASDAQ:AUTL) After Its First-Quarter Report
12:26pm, Sunday, 10'th May 2020
It's been a pretty great week for Autolus Therapeutics plc (NASDAQ:AUTL) shareholders, with its shares surging 12% to...
Autolus Therapeutics Plc (AUTL) Q1 2020 Earnings Call Transcript
03:01am, Sunday, 10'th May 2020
AUTL earnings call for the period ending March 31, 2020.
Is Autolus Therapeutics (NASDAQ:AUTL) In A Good Position To Deliver On Growth Plans?
12:26pm, Saturday, 09'th May 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Autolus Therapeutics: Q1 Earnings Insights
12:06pm, Thursday, 07'th May 2020
Shares of Autolus Therapeutics (NASDAQ:AUTL) were unchanged at $10.28 after the company reported Q1 results.Quarterly Results Earnings per share rose 13.04% year over year to ($0.60), which beat the e
Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress
11:00am, Thursday, 07'th May 2020
- Conference Call to be held on May 7, 2020 at 8:30 am EDT/1:30 pm BST- LONDON, May 07, 2020 -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical.
